Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from Stanford Medicine and international collaborators suggests these drugs may be less effective for some individuals due to genetic differences.

Click here to view the original article.